UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD)

PloS one, 2024-04, Vol.19 (4), p.e0295749-e0295749

2024

Volltextzugriff (PDF)

Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease

Nature communications, 2023-08, Vol.14 (1), p.5120-5120, Article 5120

2023

Volltextzugriff (PDF)

Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk

PloS one, 2015-10, Vol.10 (10), p.e0135076-e0135076

2015

Volltextzugriff (PDF)

Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer's disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer's dementia

Pilot and feasibility studies, 2022-12, Vol.8 (1), p.243-12, Article 243

2022

Volltextzugriff (PDF)

Longitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden

NeuroImage clinical, 2020-01, Vol.26, p.102052, Article 102052

2020

Volltextzugriff (PDF)

Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia

Postgraduate medicine, 2023-07, Vol.135 (5), p.530-538

2023

Volltextzugriff (PDF)

Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults

Alzheimer's & dementia, 2022-04, Vol.18 (4), p.645-653

2022

Volltextzugriff (PDF)

Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults

Neurobiology of aging, 2020-09, Vol.93, p.124-130

2020

Volltextzugriff (PDF)

Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease

Brain (London, England : 1878), 2024-06, Vol.147 (6), p.2158-2168

2024

Volltextzugriff (PDF)

A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial

Alzheimer's & dementia, 2023-05, Vol.19 (5), p.1938-1946

2023

Volltextzugriff (PDF)

Middle Age Prevention of Future Alzheimer’s Disease and Related Dementias with Intensive Treatment of Hypertension: Middle PATH Clinical Trial Proposal

Alzheimer's & dementia, 2023-12, Vol.19 (S23), p.n/a

Pruzin, Jeremy J.

2023

Volltextzugriff (PDF)

Middle Age Prevention of Future Alzheimer’s Disease and Related Dementias with Intensive Treatment of Hypertension: Middle PATH Clinical Trial Proposal

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

Pruzin, Jeremy J.

2023

Volltextzugriff (PDF)

Physical activity is associated with increased resting‐state fcMRI in networks predictive of cognitive decline in clinically unimpaired older adults

Alzheimer's & dementia, 2021-12, Vol.17 (S4), p.n/a

Pruzin, Jeremy J.

2021

Volltextzugriff (PDF)

Physical activity is associated with increased resting‐state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults

Alzheimer's & dementia : diagnosis, assessment & disease monitoring, 2022, Vol.14 (1), p.e12319-n/a

2022

Volltextzugriff (PDF)

The Neurologist’s Role in Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia

Alzheimer's & dementia, 2022-12, Vol.18 (S8), p.n/a

2022

Volltextzugriff (PDF)

Effects of aerobic exercise on plasma AT(N) biomarkers

Alzheimer's & dementia, 2023-06, Vol.19 (S5), p.n/a

2023

Volltextzugriff (PDF)

Alzheimer’s Disease Biomarkers: Roles of Type 2 Diabetes from the HABS‐HD Study

Alzheimer's & dementia, 2023-12, Vol.19 (S15), p.n/a

2023

Volltextzugriff (PDF)

Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists

The journal of prevention of Alzheimer's disease, 2023, Vol.10 (2), p.162-170

2023

Volltextzugriff (PDF)

Effect of Age Range on Power for a Clinical Trial Investigating the Effect of Intensive Systolic Blood Pressure Control on White Matter Hyperintensity Volume Accumulation

Alzheimer's & dementia, 2023-12, Vol.19 (S10), p.n/a

2023

Volltextzugriff (PDF)

Effect of Age Range on Power for a Clinical Trial Investigating the Effect of Intensive Systolic Blood Pressure Control on White Matter Hyperintensity Volume Accumulation

Alzheimer's & dementia, 2023-12, Vol.19 (S21), p.n/a

2023

Volltextzugriff (PDF)

High VEGF‐A and low PlGF in plasma are associated with reduced longitudinal tau PET burden and slower cognitive decline in preclinical Alzheimer’s disease

Alzheimer's & dementia, 2023-12, Vol.19 (S24), p.n/a

2023

Volltextzugriff (PDF)

Relationship of Type 2 Diabetes to Human Brain Pathology

Neuropathology and applied neurobiology, 2018-03, Vol.44 (4), p.347-362

2018

Volltextzugriff (PDF)

The combined influence of beta‐amyloid and vascular risk on prospective brain atrophy in clinically normal individuals

Alzheimer's & dementia, 2021-12, Vol.17 (S10), p.n/a

2021

Volltextzugriff (PDF)

Effect of APOE4 on Plasma Phospho‐tau 217 and Neurofilament Light in the PSEN1 E280A Autosomal Dominant Alzheimer’s Disease Colombian Kindred

Alzheimer's & dementia, 2022-12, Vol.18 (S6), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(41)

Publikationsform

Artikel
(43)
Buchkapitel
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The associations between type 2 diabetes and plasma biomarkers of Alzheimer's disease in the Health and Aging Brain Study: Health Disparities (HABS-HD)

Effect of apolipoprotein genotype and educational attainment on cognitive function in autosomal dominant Alzheimer's disease

Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk

Feasibility and preliminary effects of exercise interventions on plasma biomarkers of Alzheimer's disease in the FIT-AD trial: a randomized pilot study in older adults with Alzheimer's dementia

Longitudinal degradation of the default/salience network axis in symptomatic individuals with elevated amyloid burden

Perspectives of patients, care partners, and primary care physicians on management of mild cognitive impairment and mild Alzheimer's disease dementia

Plasma IL‐12/IFN‐γ axis predicts cognitive trajectories in cognitively unimpaired older adults

Amyloid-beta burden predicts prospective decline in body mass index in clinically normal adults

Plasma VEGFA and PGF impact longitudinal tau and cognition in preclinical Alzheimer's disease

Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals

A public resource of baseline data from the Alzheimer's Prevention Initiative Autosomal‐Dominant Alzheimer's Disease Trial

Middle Age Prevention of Future Alzheimer’s Disease and Related Dementias with Intensive Treatment of Hypertension: Middle PATH Clinical Trial Proposal

Middle Age Prevention of Future Alzheimer’s Disease and Related Dementias with Intensive Treatment of Hypertension: Middle PATH Clinical Trial Proposal

Physical activity is associated with increased resting‐state fcMRI in networks predictive of cognitive decline in clinically unimpaired older adults

Physical activity is associated with increased resting‐state functional connectivity in networks predictive of cognitive decline in clinically unimpaired older adults

The Neurologist’s Role in Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia

Effects of aerobic exercise on plasma AT(N) biomarkers

Alzheimer’s Disease Biomarkers: Roles of Type 2 Diabetes from the HABS‐HD Study

Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists

Effect of Age Range on Power for a Clinical Trial Investigating the Effect of Intensive Systolic Blood Pressure Control on White Matter Hyperintensity Volume Accumulation

Effect of Age Range on Power for a Clinical Trial Investigating the Effect of Intensive Systolic Blood Pressure Control on White Matter Hyperintensity Volume Accumulation

High VEGF‐A and low PlGF in plasma are associated with reduced longitudinal tau PET burden and slower cognitive decline in preclinical Alzheimer’s disease

Relationship of Type 2 Diabetes to Human Brain Pathology

The combined influence of beta‐amyloid and vascular risk on prospective brain atrophy in clinically normal individuals

Effect of APOE4 on Plasma Phospho‐tau 217 and Neurofilament Light in the PSEN1 E280A Autosomal Dominant Alzheimer’s Disease Colombian Kindred

Aktive Filter

Suchergebnisse filtern